These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15108036)

  • 21. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
    Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
    Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
    Vajzovic LM; Murray TG; Aziz-Sultan MA; Schefler AC; Fernandes CE; Wolfe SC; Hess DJ; Dubovy SR
    Arch Ophthalmol; 2010 Dec; 128(12):1619-23. PubMed ID: 21149791
    [No Abstract]   [Full Text] [Related]  

  • 23. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.
    Fallaha N; Dubois J; Carret AS; Callejo SA; Hamel P; Superstein R
    Arch Ophthalmol; 2012 Aug; 130(8):1075-7. PubMed ID: 22893086
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical pharmacokinetics of intra-arterial melphalan and topotecan combination in patients with retinoblastoma.
    Taich P; Ceciliano A; Buitrago E; Sampor C; Fandino A; Villasante F; Lucena E; Romero L; Chantada GL; Schaiquevich P
    Ophthalmology; 2014 Apr; 121(4):889-97. PubMed ID: 24359624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
    Hutchinson A; Kaliki S; Shields CL
    J Pediatr Ophthalmol Strabismus; 2012 Mar; 49 Online():e15-8. PubMed ID: 22443587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
    Padrón-Pérez N; Català-Mora J
    J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
    [No Abstract]   [Full Text] [Related]  

  • 28. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
    Tsimpida M; Thompson DA; Liasis A; Smith V; Kingston JE; Sagoo MS; Reddy MA
    Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.
    Shields CL; Bianciotto CG; Jabbour P; Griffin GC; Ramasubramanian A; Rosenwasser R; Shields JA
    Arch Ophthalmol; 2011 Nov; 129(11):1407-15. PubMed ID: 21670326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
    Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
    Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
    Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.
    Sarici A; Kizilkilic O; Celkan T; Gode S
    JAMA Ophthalmol; 2013 Jun; 131(6):801-2. PubMed ID: 23764710
    [No Abstract]   [Full Text] [Related]  

  • 34. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma.
    Aziz HA; Boutrid H; Murray TG; Berrocal A; Wolfe SQ; Pina Y; Dorfman M; Moftakhar R; Fernandes CE; Reichbach J; Aziz-Sultan MA
    Retina; 2010 Apr; 30(4 Suppl):S63-5. PubMed ID: 20224464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zygomatico-orbital intra-arterial melphalan infusion for intraocular retinoblastoma.
    Cooke D; Farid H; Kim W; Dowd C; Higashida R; Halbach V
    J Neurointerv Surg; 2012 Jul; 4(4):e16. PubMed ID: 21990490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete regression of retinoblastoma following intra-arterial chemotherapy.
    Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
    J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.
    Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL
    Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
    Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
    Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
    Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.